KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.

Practicality of Home QT Measurement

New FDA guidance allows use of KardiaMobile 6L to measure QTc in COVID-19 patients

Alivecor's Kardiamobile 6L joins COVID-19 fight to detect QT prolongation, 2020-03-23

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library

Accuracy of mobile 6-lead electrocardiogram device for assessment of QT interval: a prospective validation study

ECG register with KardiaMobile-6L.

COVID-19 Archives - Cardiac Rhythm News

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health

PDF) Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients

FDA approves AliveCor's ECG device for QTc interval measuring